Skip to main content
. Author manuscript; available in PMC: 2020 Jan 9.
Published in final edited form as: Curr Opin Investig Drugs. 2009 May;10(5):463–473.

Table 1.

A summary of studies of cytokine levels in individuals with autism spectrum disorder.

Cytokine/
chemokine tested
Change detected in
cytokine/chemokine levels
in patients with ASD
Tissue source Method Reference
Th1-associated cytokines
IFNγ Increased CSF, brain tissue, whole blood, plasma and cultured PBMCs Luminex and ELISA [11,63,64,66,67]
IFNγ No change Plasma ELISA [69]
IFNγ + T-cells Decreased Cultured PBMCs Flow cytometry [65]
IL-12 Increased Plasma ELISA [11]
IL-2 Increased Serum and cultured PBMCs ELISA [8,66]
IL-2 No Change Brain tissue Luminex [63]
IL-2 + T-cells Decreased Cultured PBMCs Flow cytometry [65]
Acute inflammatory cytokines
IL-1β Increased Brain tissue and stimulated PBMCs Luminex and ELISA [63,115]
IL-1β No change Plasma ELISA [69]
IL-6 Increased CSF, brain tissue and cultured PBMCs Luminex and ELISA [63,64,67,115]
IL-6 No change Plasma, serum and cultured PBMCs ELISA and flow cytometry [7,11,65]
TNFα Increased Brain tissue and cultured PBMCs Luminex and ELISA [63,67,115]
TNFα No change Plasma ELISA [11,69]
TNFRI Increased Stimulated PBMCs ELISA [115]
TNFRII Increased Stimulated PBMCs and serum ELISA [7,115]
IL-8 Increased CSF and brain tissue Luminex [63,64]
MCP-1 Increased CSF and brain tissue Luminex and ELISA [64]
MIP-1β Increased CSF Luminex [64]
TGFβ Increased Brain tissue Luminex and ELISA [64]
TGFβ Decreased Plasma ELISA [70,71]
GM-CSF Increased Brain tissue Luminex [63]
Th2-associated cytokines
IL-4 Increased Cultured PBMCs ELISA and flow cytometry [66,65]
IL-4 No change Brain tissue Luminex [63]
IL-5 Increased Cultured PBMCs ELISA [63,66]
IL-5 No change Brain tissue Luminex [63]
IL-10 No change Brain tissue and cultured PBMCs Luminex, ELISA and flow cytometry [63,65,66]
IL-13 Increased Cultured PBMCs ELISA [66]

Four studies were excluded from this table because children with autism spectrum disorder (ASD) that were recruited in these excluded studies experienced gastrointestinal symptoms, which may confound cytokine results [9,12,68,116].

MCP-1 monocyte chemotactic protein 1, MIP-1β macrophage inflammatory protein 1β, TNFRI TNF receptor 1, TNFRII TNF receptor II